RE:RE:RE:RE:Both Roche and Incyte have turned me down as an MSLMaybe Adlai is maneuvering to take a run at owning Oncy outright. They say they want to be a leader in the next wave of immuno oncology and Pela is just that. They'd need backing to pull off such a huge acquisition tho...perhaps Japan's Takeda?